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Introduction
Inflammatory bowel disease (IBD) has emerged as a global 
disease. Temporal trends indicate an increasing incidence and 
prevalence across various regions of the world.[1] Whereas 
this increase has largely been attributed to environmental 
influences consequent on urbanization and industrialization, 
better diagnostic tools and increased awareness by physicians 
have been contributory. The disease burden may be plateauing 
in Western nations, but this is not the case in previously 
low incidence regions like Eastern Europe, Asia and other 
developing nations.[2] In Nigeria and indeed Africa, there is still 
the perception among physicians that ulcerative colitis (UC) is 
a rare disease. However, the increasing reports from Nigeria of 
this subtype of IBD does suggest that the few case reports and 
case series in literature may just be the tip of the iceberg.[3-5] 
This condition is most likely an under diagnosed problem in 
our environment. We report a case series of UC seen over an 
18 months period at two South-eastern Nigerian centres with 
active gastrointestinal endoscopy services: Federal Medical 
Centre Owerri and Carez Clinic Owerri. This will serve as 




A 64 Nigerian male was referred to our general surgery outpatient 
clinic on account of 6 months history of progressive weight 
loss, frequent stooling 5–7 times per day and haematochezia. 
He had similar bowel complaints 2 years prior to presentation 
which subsided on unspecified medications. He has had no 
previous surgical operation. He looked cachetic and anaemic 
on examination with tenderness on the right upper quadrant 
of the abdomen. Abdominal computed tomography (CT) done 
showed thickened bowel which was initially suggested to be a 
neoplasm of the colon. However, further evaluation of the CT 
images showed circumferential and diffuse thickening of the 
rectum as well as the colon; features which are indicative of an 
inflammatory condition [Figure 1]. On account of the ongoing 
blood loss he had an emergency laparotomy. There was no 
tumour found intraoperatively, rather gross inflammation of 
the entire colon, more pronounced on the descending and 
sigmoid and transverse colon was noticed. Subtotal colectomy 
was done. Photomicrograph of the resected bowel segment is 
as shown [Figure 2]. Postoperatively patient had anastomotic 
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leakage that was managed conservatively. Subsequently, the 
patient has been maintained on intermittent sulphasalazine 
for 14 months. During an episode of relapse he was placed 
on prednisolone but has to be stopped on account of diabetes 
mellitus. Infliximab was prescribed for him but it has been 
difficult to access it.
Case 2
A 30-year-old lady presented with a 7 years history abdominal 
cramps, 4–9 bowel motions per day that warranted the use of 
diapers. At the disease onset she was managed in a teaching 
hospital in neighbouring state where she was admitted 
for 35 days. During this period she developed widespread 
suppurative skin lesions. No definitive diagnosis of her condition 
was made. Subsequently she has been in and out of hospitals 
on account of febrile illness and abdominal complaints that 
usually required intravenous fluid and antibiotic resuscitation. 
A suspicion of UC was made and barium enema requested. 
It showed loss of haustral markings over the entire length of 
the colon with evidence of pseudopolyps [Figure 3]. This was 
confirmed at colonoscopy. She has been on sulphalazine with 
marked relief of her symptoms.
Case 3
A 41-year-old Nigerian woman presented with a 32 months 
history of passage of loose stools, 7–8 motions per day, 
mixed with fresh blood. She occasionally passes blood clots 
per rectum and has been losing weight. She has received 
medications at various clinics for diarrhoeal disease without 
relief. She had erythema nodosum on the dorsum of the left 
foot. A diagnosis of IBD was suspected and she underwent 
colonoscopy. Findings included friable mucosal inflammation 
of the entire rectum and colon as well as a pedunculated 
1.5 cm diameter polyp at the descending colon. Histologic 
sections of the intestinal mucosa tissue fragments showed 
heavy infiltration of the lamina propria by neutrophils and 
occasional lymphocytes and plasma cells. Features of crypt 
abscesses, cryptitis, epithelial damage (mucin depletion) and 
crypt distortion were also seen [Figure 4]. She was placed 
on sulphasalazine, which she takes irregularly on account 
of difficulty in sourcing it. However, stool frequency has 
decreased to 2–3/day, although it is still bloody.
Discussion
Ulcerative colitis is reportedly very rare in black Africans 
compared to Western populations.[6] The appreciable data 
from the disease is mainly from South Africa. This could 
be attributed to the better health system infrastructure in 
that country juxtaposed with other sub-Saharan African 
countries. There are no large patient series from Nigeria 
despite its population of about 160 million. This becomes 
more worrisome when neighbouring smaller countries seem 
to have comparatively larger reported cases. A report from 
Senegal revealed 32 cases of UC over a 7 years period while 
from Burkina Faso, Bougouma published 20 cases seen 
between 1st January 1995 and 21st May 2006.[7,8] Apart from 
the compounding problems of absence of population based 
health surveys and adequate medical recording system, the 
perception that UC is a disease of the Caucasian population 
points to condition that is potentially under-diagnosed.
Figure 1: Computed tomography scan mage showing thickened 
rectal wall
Figure 2: Photomicrograph of the colon showing crypt abscess and 
reactive colonic epithelium with marked mucosal inflammation
Figure 3: Barium enema of case 2
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Diagnostic delay is a topical issue in the management of IBD in 
several countries. The Swiss IBD cohort study group reported a 
median diagnostic delay of 4 months from the onset of symptoms 
to a diagnosis of UC which is significantly shorter than that for 
Crohn’s.[9] The alarming nature of bloody diarrhea may be a 
contributory factor for the earlier diagnosis of UC. However, the 
delay in the diagnosis of our cases is unduly too long. This may 
be the reason why all our patients presented with severe disease 
and associated pancolitis. Patients are likely to self-medicate 
when they have mild bloody diarrhea as was the case in our 
first patient. Physicians are also more likely to attribute bloody 
diarrhea to amoebic colitis, other bacterial infective causes 
prevalent in the tropics, human immunodeficiency virus and 
less commonly to colonic neoplasia.[10] Thus it is the severe 
case that gets to be investigated more comprehensively. Even 
in this regard options are limited because colonoscopy facilities 
are still rudimentary in many parts of Nigeria. In our centre, 
it is barely 1-year. The poor radiologic service in our practice 
is also being highlighted by this study. The initial CT scan 
report for Case 1 suggested colonic malignancy as cause of the 
haemorrhage. It was only in hindsight that another radiologist 
was able to outline the diffuse thickening of the bowel that is 
in keeping with an inflammatory process.[11]
As an aid in diagnosis, it needs to be reinforced among our 
physicians that the skin is the most common extraintestinal 
organ to be affected in IBD.[12,13] Two of our patients had 
skin manifestation which heightened our suspicion of UC. 
A drawback in this regard is that there is a huge dearth of 
dermatologists in our country.
Treatment of patients with UC has profound challenges 
in our society. It may be difficult sourcing the basic drug, 
sulphasalazine. The national drug agency does not seem to have 
any company that is licensed to import it. Patients occasionally 
get supplies from neighbouring countries. In order to access 
infliximab a special application had to be made to the same 
agency. Ultimately this makes costs prohibitive for patients. 
We believe that establishing a national database on UC is 
pertinent at the moment; as the disease condition becomes 
increasingly diagnosed and reported in our environment. 
This will make some sense from the various cases reported 
from some various health institutions. It will also provide the 
opportunity for timely and indigenous research on a condition 
that will likely compound the various health challenges in a 
sub-Saharan African environment.
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